Skip to main content
. 2016 Jun 23;115(3):297–302. doi: 10.1038/bjc.2016.191

Table 2. Characteristics of 90Y-TARE treatment.

BSA 1.9±0.3 (range 1.4–2.3)
Lung shunt study (%) Median: 3 (1.4–6)
Treatment target  
 Whole liver 0
 Right lobe 5 (22%)
 Left lobe 3 (13%)
 Segmental 5 (22%)
 Multisegmental 10 (43%)
Targeted liver volume (ml) 1056±484 (range: 297–1820)
Targeted tumour volume (ml) 180±163 (range: 7–572)
Delivered activity (GBq) 1.5±0.4 (range: 0.8–2.24)
Length of hospitalisation (hours)  
 <24 0
 24–72 18 (86%)
 >72 3 (14%)

Abbreviation: BSA=body surface area.